Puede mejorar la memoria, la atencin y el rendimiento mental, incluso cuando hay daos cerebrales
Meet GLP-1s: Your Weight Loss Ally GLP-1s (glucagon-like peptide-1) are medications originally developed to treat type 2 diabetes
Understanding the differences between these medications, including how they affect metabolism, appetite, and overall weight management, can help patients make informed decisions
This activation increases melanin production (melanogenesis) in the skin, leading to enhanced pigmentation and protection against UV radiation
A reasonable approach includes: Baseline thyroid function tests (TSH and FT4) before starting GLP-1 therapy Repeat testing at 812 weeks after commencing treatment, particularly if significant weight loss occurs Further monitoring at 6 months , then annually if thyroid function remains stable Additional testing if symptoms of thyroid dysfunction develop After any levothyroxine dose change, NICE NG145 recommends re-checking thyroid function in 68 weeks to assess the adequacy of the adjustment
The Journal of Maternal-Fetal & Neonatal Medicine, 26 (10), 967972